Holen Sie sich die Stockscreener-App
0.2265
3.62%
-0.0085
Handel nachbörslich:
.23
0.0035
+1.55%
Schlusskurs vom Vortag:
$0.235
Offen:
$0.225
24-Stunden-Volumen:
672.60K
Relative Volume:
1.13
Marktkapitalisierung:
$18.40M
Einnahmen:
$3.38M
Nettoeinkommen (Verlust:
$-15.06M
KGV:
-0.9659
EPS:
-0.2345
Netto-Cashflow:
$-15.50M
1W Leistung:
-0.66%
1M Leistung:
-19.14%
6M Leistung:
-67.68%
1J Leistung:
-78.63%
1-Tages-Spanne:
$0.22
$0.2295
1-Wochen-Bereich:
$0.2181
$0.2425
52-Wochen-Spanne:
$0.215
$1.40
Icecure Medical Ltd Stock (ICCM) Company Profile
Firmenname
Icecure Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.2265 | 19.09M | 3.38M | -15.06M | -15.50M | -0.2345 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Icecure Medical Ltd Aktie (ICCM) Neueste Nachrichten
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... By GuruFocus - Investing.com Canada
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Rob - GuruFocus
Icecure Medical Earnings Call Highlights Growth Momentum - TipRanks
IceCure Medical presents positive ProSense cryoablation data - grafa.com
IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for - GuruFocus
IceCure Showcases Strong ProSense® Cryoablation Data and Surge in Clinical Interest at ECIO 2026 - TipRanks
IceCure Medical (ICCM) highlights kidney and breast cryoablation data at ECIO 2026 - Stock Titan
IceCure Medical Ltd. Reports Nearly 90% Recurrence-Free Rate For Cryoablation Of Kidney Cancer And Showcases ProSense At ECIO 2026 - marketscreener.com
[Form 4] IceCure Medical Ltd. Insider Trading Activity - Stock Titan
IceCure Medical : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
IceCure Medical (ICCM) CFO reports 400,000 RSUs equity grant - Stock Titan
IceCure Medical Ltd. (ICCM) reports Q1 loss, lags revenue estimates - MSN
IceCure Medical Ltd.Ordinary Shares (NQ: ICCM - The Chronicle-Journal
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $1 - Moomoo
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Cuts Target Price to $1 - Moomoo
ICCM Maintained by Maxim Group -- Price Target Lowered to $1.00 - GuruFocus
IceCure Medical Wins Nasdaq Extension to Restore Minimum Bid Compliance - The Globe and Mail
IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - The Malaysian Reserve
Icecure granted 180-day extension by Nasdaq to regain compliance with minimum bid requirement - marketscreener.com
IceCure Medical (ICCM) wins new 180-day window to meet Nasdaq $1 bid - Stock Titan
IceCure Medical Ltd (NASDAQ:ICCM) Q1 2026 Earnings Call Transcript - Insider Monkey
IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America - StreetInsider
ICECURE MEDICAL ($ICCM) Releases Q1 2026 Earnings - Moomoo
[424B5] IceCure Medical Ltd. Prospectus Supplement (Debt Securities) - Stock Titan
IceCure Medical Sets Up At-the-Market Equity Program With A.G.P./Alliance Global Partners - TipRanks
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC FilingForm 6-K - Stock Titan
ICCM: Strong Q1 Revenue Growth Signals Positive Market Momentum - GuruFocus
IceCure (ICCM) Q1 2026 Earnings Transcript - AOL.com
IceCure Reports First Quarter 2026 Financial Results: ProSense® - GuruFocus
ICCM: Q1 2026 revenue up 26% year-over-year, driven by U.S. growth and post-FDA commercial momentum - TradingView
ICCM: Q1 2026 saw 26% revenue growth and accelerating U.S. adoption following FDA clearance - TradingView
ICCM: ProSense® sales soared post-FDA clearance, fueling robust revenue growth and U.S. adoption - TradingView
IceCure Medical Posts Strong Q1 2026 ProSense® Growth in U.S. After FDA Clearance - TipRanks
IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
IceCure Medical (NASDAQ: ICCM) grows Q1 2026 revenue but posts $4.3M loss - Stock Titan
IceCure Medical (NASDAQ:ICCM) Shares Slide Over 7% Premarket After Q1 Revenue Miss - ChartMill
Press Release: IceCure Reports First Quarter 2026 Financial Results: ProSense(R) Sales Increase Substantially in the U.S. and North America - Moomoo
IceCure Medical Q1 2026 Earnings Call Transcript - MarketBeat
IceCure Medical Shareholders Approve Agenda Item at May 11 Special Meeting After Initial Adjournment - TipRanks
IceCure Medical (ICCM) shareholders approve agenda item after adjourned meeting - Stock Titan
Why Has IceCure Medical's Stock Price Collapsed - Kavout
ICCM Stock Price, Quote & Chart | ICECURE MEDICAL LTD (NASDAQ:ICCM) - ChartMill
IceCure Medical Faces Certified Class Action in Israel Over 2021 Private Placement - TipRanks
IceCure Medical to Release First Quarter 2026 Financial Results on May 12 - geneonline.com
IceCure to release Q1 results before market, webcast at 11 a.m. EDT - Stock Titan
IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026 - marketscreener.com
IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market - Quantisnow
A. G. P. Initiates Icecure Medical(ICCM.US) With Buy Rating, Announces Target Price $1 - Moomoo
IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates - MSN
IceCure prices $4M direct offering, concurrent private placement - MSN
Finanzdaten der Icecure Medical Ltd-Aktie (ICCM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):